Small-molecule therapy for metastatic prostate cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R41CA217491
- Recipient
-
Metcure Therapeutics LLC UEI CGKMNL6SUY65
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,999
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Augusta, GA 30912, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $224,999 |
Quick answers
Who received award R41CA217491?
R41CA217491 was awarded to Metcure Therapeutics LLC by National Cancer Institute (National Institutes of Health) on August 1, 2017.
How much is award R41CA217491 worth?
$224,999 has been obligated on R41CA217491.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award